The demographic data for the individual studies are reported elsewhere. The 27 patients not included in the efficacy evaluable analysis comprised 14 patients who treated a headache that did not meet the protocol criteria for a migraine, nine who did not complete their evaluations at 2-hours postdose, and four who did not take the full dose of study medication. Moreover, the profiles of the patients participating in the three studies were comparable to those reported in the literature. Similar results were also obtained from the patient global evaluations. The significance was observed at 0.5 hours postdose and continued through to the 6-hour time point.
Migraine formulation is effective for the treatment of acute migraine headache pain.
Back to the Top References Lipton RB, Stewart WF, Ryan RE Jr., Saper J, Silberstein S, Sheftell F. Efficacy and safety of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating headache pain of an acute migraine attack. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Arch Intern Med. Celentano DD, Stewart WF, Lipton RB, Reed M. Medication use and disability among migraineurs.